In addition to leading one of the U.S. sales teams for GSK’s Respiratory business, Anton also serves as the Vice Chair of the GSK PAC Board of Directors. His leadership has driven higher employee participation in the GSK PAC Ambassador program and encouraged employees to pursue future opportunities for the PAC.
Outside of helping change the treatment landscape for people with bladder cancer, Dr. Cutie is also engaged in the legislative world. In June 2025, he participated in the PhRMA Researcher Fly-In. He spoke to policymakers about the physical and mental health challenges of patients facing a bladder cancer diagnosis and his work in building toward
Matthew has advocated for the industry in Washington, D.C. and hosted several key engagements in Indianapolis to meet with lawmakers, congressional staff, veteran organizations, and trade associations. He also welcomes statewide elected officials and other influential stakeholders to the Indianapolis facility, offering firsthand insight into the science and innovation driving radioligand therapy.
Navin takes the time to collaborate with the Pfizer US Policy and Government relations team, advocating for key innovation and patient access policies. He works to educate policymakers on the importance of removing barriers to help ensure innovative companies like Pfizer can achieve breakthroughs that improve patients’ lives.
Jeannette has led a groundbreaking Social Determinants of Health (SDOH) initiative in partnership with a major national payer, encompassing the entire UCB portfolio. This initiative has informed targeted educational campaigns nationwide and provided foundational insights for 2025–2026 real-world study strategies.
VCN raises awareness and provides a sense of community across the company around military service members, veterans and their family members and nonmilitary employees who just want to help. VCN works with veteran organizations and actively provides mentoring opportunities for former service members to assist in their transition to a career outside the military. Bristol-Myers
Based at Pfizer’s La Jolla (CA) site, Bob understands the importance of community and patient engagement. Under Bob’s leadership, he has hosted patient advocacy groups at the site and speaks to organizations like the San Diego Komen for the Metastatic Breast Cancer Conference and other charitable related events.
Vanessa, in partnership with her colleague, Dr. Anderson, served as the U.S. D&I leads for the Employee Resource Group (ERG) Capitol Hill Fly-In. They worked to produce content, align with ERG associates for the opportunity and partnered with Public Affairs to execute the initiative. The Fly-in provided Novartis associates who participate in ERGs with an
(Bristol-Myers Squibb) – Sabrina is a board member of BUILD, an organization that partners with high schools in Palo Alto, Oakland, Boston and Washington, DC, to use a four-year curriculum of youth entrepreneurship to engage and propel low income, disengaged youth in tough neighborhoods through high school and into college.
(Novo Nordisk) – Andrew took the lead in the company’s drive to increase advocacy, committing his entire leadership team of 61 employees to come to Washington this month for Advocacy Day. He plans to bring 150 sales executives to Washington in the fall for a second Advocacy Day.